Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With $450M sale, Alnylam has more cash than any pre-commercial biotech
With $450M sale, Alnylam has more cash than any pre-commercial biotech
With $450M sale, Alnylam has more cash than any pre-commercial biotech
Submitted by
admin
on January 20, 2015 - 2:00pm
Source:
Bizjournals.com
News Tags:
Alnylam
biotech
Headline:
With $450M sale, Alnylam has more cash than any pre-commercial biotech
Do Not Allow Advertisers to Use My Personal information
